Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

Clinical trial NCT04641884 · UNKNOWN

Trial details

NCT number: NCT04641884
Sponsor: Nantes University Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Bullous Pemphigoid Immunotherapy Programmed Cell Death Ligand 1

Start date: 2020-04-01
Primary completion: 2021-04-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.